Plain-English translation of NCT00897117 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This research study collects excess lung tissue that is removed during surgery for early-stage lung cancer and analyzes it in the laboratory. Researchers study the proteins and genetic material in the tissue to develop a molecular fingerprint—a unique pattern that can predict how aggressive the cancer is and whether it's likely to come back after surgery. This information could help doctors better understand which patients are at higher risk and may need additional treatment.
Currently, doctors have limited tools to predict which patients with early-stage lung cancer will do well after surgery and which ones may experience cancer recurrence. By studying the molecular fingerprints in tumor tissue, researchers hope to develop better ways to identify high-risk patients and eventually personalize treatment plans.
You likely qualify if…
You likely don't qualify if…
If you join this study, your participation is straightforward: any extra lung tissue that is removed during your cancer surgery and would normally be discarded will be used for research instead. Researchers will analyze this tissue in the laboratory to study protein and genetic patterns. Your medical records will be reviewed to gather information about your cancer stage and surgery results, and you will be followed over time through chart review to track how you recover and whether your cancer returns.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States